The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Humira Biosimilar Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2029
Synopsis
The global Humira Biosimilar market size was valued at USD 433.2 million in 2022 and is forecast to a readjusted size of USD 955.4 million by 2029 with a CAGR of 12.0% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The introduction of Humira biosimilars is expected to increase competition in the market, leading to lower prices and improved access to treatment for patients. The availability of biosimilars provides an alternative option for healthcare providers and payers to choose from, potentially reducing the overall healthcare expenditure associated with biologic treatments.
Humira is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation.
This report is a detailed and comprehensive analysis for global Humira Biosimilar market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Humira Biosimilar market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Humira Biosimilar market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Humira Biosimilar market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Humira Biosimilar market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Humira Biosimilar
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Humira Biosimilar market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cadila Healthcare, Torrent Pharmaceuticals, Amgen, Boehringer Ingelheim and Novartis, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Humira Biosimilar market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Syringe
Pen
Market segment by Application
Ankylosing Spondylitis
Rheumatoid Arthritis
Crohn’s Disease
Other
Major players covered
Cadila Healthcare
Torrent Pharmaceuticals
Amgen
Boehringer Ingelheim
Novartis
Samsung Bioepis
Viatris
Pfizer
Fresenius Kabi
Coherus
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Humira Biosimilar product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Humira Biosimilar, with price, sales, revenue and global market share of Humira Biosimilar from 2018 to 2023.
Chapter 3, the Humira Biosimilar competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Humira Biosimilar breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Humira Biosimilar market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Humira Biosimilar.
Chapter 14 and 15, to describe Humira Biosimilar sales channel, distributors, customers, research findings and conclusion.
The global Humira Biosimilar market size was valued at USD 433.2 million in 2022 and is forecast to a readjusted size of USD 955.4 million by 2029 with a CAGR of 12.0% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The introduction of Humira biosimilars is expected to increase competition in the market, leading to lower prices and improved access to treatment for patients. The availability of biosimilars provides an alternative option for healthcare providers and payers to choose from, potentially reducing the overall healthcare expenditure associated with biologic treatments.
Humira is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation.
This report is a detailed and comprehensive analysis for global Humira Biosimilar market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Humira Biosimilar market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Humira Biosimilar market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Humira Biosimilar market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Humira Biosimilar market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Humira Biosimilar
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Humira Biosimilar market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cadila Healthcare, Torrent Pharmaceuticals, Amgen, Boehringer Ingelheim and Novartis, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Humira Biosimilar market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Syringe
Pen
Market segment by Application
Ankylosing Spondylitis
Rheumatoid Arthritis
Crohn’s Disease
Other
Major players covered
Cadila Healthcare
Torrent Pharmaceuticals
Amgen
Boehringer Ingelheim
Novartis
Samsung Bioepis
Viatris
Pfizer
Fresenius Kabi
Coherus
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Humira Biosimilar product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Humira Biosimilar, with price, sales, revenue and global market share of Humira Biosimilar from 2018 to 2023.
Chapter 3, the Humira Biosimilar competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Humira Biosimilar breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Humira Biosimilar market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Humira Biosimilar.
Chapter 14 and 15, to describe Humira Biosimilar sales channel, distributors, customers, research findings and conclusion.
Index1 Market Overview
1.1 Product Overview and Scope of Humira Biosimilar
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Humira Biosimilar Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Syringe
1.3.3 Pen
1.4 Market Analysis by Application
1.4.1 Overview: Global Humira Biosimilar Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Ankylosing Spondylitis
1.4.3 Rheumatoid Arthritis
1.4.4 Crohn’s Disease
1.4.5 Other
1.5 Global Humira Biosimilar Market Size & Forecast
1.5.1 Global Humira Biosimilar Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Humira Biosimilar Sales Quantity (2018-2029)
1.5.3 Global Humira Biosimilar Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Cadila Healthcare
2.1.1 Cadila Healthcare Details
2.1.2 Cadila Healthcare Major Business
2.1.3 Cadila Healthcare Humira Biosimilar Product and Services
2.1.4 Cadila Healthcare Humira Biosimilar Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Cadila Healthcare Recent Developments/Updates
2.2 Torrent Pharmaceuticals
2.2.1 Torrent Pharmaceuticals Details
2.2.2 Torrent Pharmaceuticals Major Business
2.2.3 Torrent Pharmaceuticals Humira Biosimilar Product and Services
2.2.4 Torrent Pharmaceuticals Humira Biosimilar Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Torrent Pharmaceuticals Recent Developments/Updates
2.3 Amgen
2.3.1 Amgen Details
2.3.2 Amgen Major Business
2.3.3 Amgen Humira Biosimilar Product and Services
2.3.4 Amgen Humira Biosimilar Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Amgen Recent Developments/Updates
2.4 Boehringer Ingelheim
2.4.1 Boehringer Ingelheim Details
2.4.2 Boehringer Ingelheim Major Business
2.4.3 Boehringer Ingelheim Humira Biosimilar Product and Services
2.4.4 Boehringer Ingelheim Humira Biosimilar Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Boehringer Ingelheim Recent Developments/Updates
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business
2.5.3 Novartis Humira Biosimilar Product and Services
2.5.4 Novartis Humira Biosimilar Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Novartis Recent Developments/Updates
2.6 Samsung Bioepis
2.6.1 Samsung Bioepis Details
2.6.2 Samsung Bioepis Major Business
2.6.3 Samsung Bioepis Humira Biosimilar Product and Services
2.6.4 Samsung Bioepis Humira Biosimilar Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Samsung Bioepis Recent Developments/Updates
2.7 Viatris
2.7.1 Viatris Details
2.7.2 Viatris Major Business
2.7.3 Viatris Humira Biosimilar Product and Services
2.7.4 Viatris Humira Biosimilar Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Viatris Recent Developments/Updates
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Humira Biosimilar Product and Services
2.8.4 Pfizer Humira Biosimilar Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Pfizer Recent Developments/Updates
2.9 Fresenius Kabi
2.9.1 Fresenius Kabi Details
2.9.2 Fresenius Kabi Major Business
2.9.3 Fresenius Kabi Humira Biosimilar Product and Services
2.9.4 Fresenius Kabi Humira Biosimilar Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Fresenius Kabi Recent Developments/Updates
2.10 Coherus
2.10.1 Coherus Details
2.10.2 Coherus Major Business
2.10.3 Coherus Humira Biosimilar Product and Services
2.10.4 Coherus Humira Biosimilar Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Coherus Recent Developments/Updates
3 Competitive Environment: Humira Biosimilar by Manufacturer
3.1 Global Humira Biosimilar Sales Quantity by Manufacturer (2018-2023)
3.2 Global Humira Biosimilar Revenue by Manufacturer (2018-2023)
3.3 Global Humira Biosimilar Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Humira Biosimilar by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Humira Biosimilar Manufacturer Market Share in 2022
3.4.2 Top 6 Humira Biosimilar Manufacturer Market Share in 2022
3.5 Humira Biosimilar Market: Overall Company Footprint Analysis
3.5.1 Humira Biosimilar Market: Region Footprint
3.5.2 Humira Biosimilar Market: Company Product Type Footprint
3.5.3 Humira Biosimilar Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Humira Biosimilar Market Size by Region
4.1.1 Global Humira Biosimilar Sales Quantity by Region (2018-2029)
4.1.2 Global Humira Biosimilar Consumption Value by Region (2018-2029)
4.1.3 Global Humira Biosimilar Average Price by Region (2018-2029)
4.2 North America Humira Biosimilar Consumption Value (2018-2029)
4.3 Europe Humira Biosimilar Consumption Value (2018-2029)
4.4 Asia-Pacific Humira Biosimilar Consumption Value (2018-2029)
4.5 South America Humira Biosimilar Consumption Value (2018-2029)
4.6 Middle East and Africa Humira Biosimilar Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Humira Biosimilar Sales Quantity by Type (2018-2029)
5.2 Global Humira Biosimilar Consumption Value by Type (2018-2029)
5.3 Global Humira Biosimilar Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Humira Biosimilar Sales Quantity by Application (2018-2029)
6.2 Global Humira Biosimilar Consumption Value by Application (2018-2029)
6.3 Global Humira Biosimilar Average Price by Application (2018-2029)
7 North America
7.1 North America Humira Biosimilar Sales Quantity by Type (2018-2029)
7.2 North America Humira Biosimilar Sales Quantity by Application (2018-2029)
7.3 North America Humira Biosimilar Market Size by Country
7.3.1 North America Humira Biosimilar Sales Quantity by Country (2018-2029)
7.3.2 North America Humira Biosimilar Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Humira Biosimilar Sales Quantity by Type (2018-2029)
8.2 Europe Humira Biosimilar Sales Quantity by Application (2018-2029)
8.3 Europe Humira Biosimilar Market Size by Country
8.3.1 Europe Humira Biosimilar Sales Quantity by Country (2018-2029)
8.3.2 Europe Humira Biosimilar Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Humira Biosimilar Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Humira Biosimilar Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Humira Biosimilar Market Size by Region
9.3.1 Asia-Pacific Humira Biosimilar Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Humira Biosimilar Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Humira Biosimilar Sales Quantity by Type (2018-2029)
10.2 South America Humira Biosimilar Sales Quantity by Application (2018-2029)
10.3 South America Humira Biosimilar Market Size by Country
10.3.1 South America Humira Biosimilar Sales Quantity by Country (2018-2029)
10.3.2 South America Humira Biosimilar Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Humira Biosimilar Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Humira Biosimilar Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Humira Biosimilar Market Size by Country
11.3.1 Middle East & Africa Humira Biosimilar Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Humira Biosimilar Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Humira Biosimilar Market Drivers
12.2 Humira Biosimilar Market Restraints
12.3 Humira Biosimilar Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Humira Biosimilar and Key Manufacturers
13.2 Manufacturing Costs Percentage of Humira Biosimilar
13.3 Humira Biosimilar Production Process
13.4 Humira Biosimilar Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Humira Biosimilar Typical Distributors
14.3 Humira Biosimilar Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
